
Chimerix, Inc. (NASDAQ: CMRX), relating to the proposed merger with Jazz Pharmaceuticals. Under the terms of the agreement, Chimerix shareholders will receive $8.55 per share.
Chimerix, Inc. (NASDAQ: CMRX), relating to the proposed merger with Jazz Pharmaceuticals. Under the terms of the agreement, Chimerix shareholders will receive $8.55 per share.
Notifications